"Early" withdrawal of glucocorticosteroids is well tolerated by kidney transplant recipients without increasing allograft rejection while preserving bone integrity

Transplantation. 2014 Dec 27;98(12):1255-6. doi: 10.1097/TP.0000000000000350.

Author

Eli A Friedman¹

Affiliation

¹ 1 Nephrology Division, Department of Medicine, State University of New York, Downstate Medical Center, Brooklyn, NY. 2 Address correspondence to: Eli A. Friedman, M.D., Department of Medicine, Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, New York 11203.

PMID: 25136846
DOI: 10.1097/TP.0000000000000350

No abstract available

MeSH terms

Adult
Allografts
Bone and Bones / drug effects*
Bone and Bones / pathology
Calcitriol / metabolism
Female
Fibroblast Growth Factor-23
Fibroblast Growth Factors / metabolism
Glucocorticoids / administration & dosage*
Glucocorticoids / therapeutic use
Graft Rejection*
Humans
Hyperparathyroidism / drug therapy
Immunosuppressive Agents / administration & dosage*
Immunosuppressive Agents / therapeutic use
Kidney Failure, Chronic / surgery*
Kidney Transplantation*
Male
Middle Aged
Risk Factors
Steroids / administration & dosage
Steroids / therapeutic use

Substances

Glucocorticoids
Immunosuppressive Agents
Steroids
Fibroblast Growth Factors
Fibroblast Growth Factor-23
Calcitriol